Detalhe da pesquisa
1.
Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease.
Int J Neurosci
; 126(1): 30-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25495896
2.
Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States.
Int J Hepatol
; 2021: 8542179, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211786
3.
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Neurology
; 90(20): e1805-e1814, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695594
4.
A fixed-dose, dose-response study of ropinirole prolonged release in early stage Parkinson's disease.
Neurodegener Dis Manag
; 7(1): 49-59, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120629
5.
A randomized, fixed-dose, dose-response study of ropinirole prolonged release in advanced Parkinson's disease.
Neurodegener Dis Manag
; 7(1): 61-72, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120630
6.
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
J Clin Psychiatry
; 66(8): 974-81, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16086611
7.
Challenges and opportunities in designing clinical trials for neuromyelitis optica.
Neurology
; 84(17): 1805-15, 2015 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25841026
8.
Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
CNS Drugs
; 26(9): 773-80, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22849331
9.
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.
J Clin Psychiatry
; 67(6): 865-73, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16848645